Endoscopic submucosal dissection for the treatment of neoplastic lesions in the gastrointestinal tract. 2013

Andrzej Białek, and Anna Wiechowska-Kozłowska, and Jan Pertkiewicz, and Katarzyna Karpińska, and Wojciech Marlicz, and Piotr Milkiewicz, and Teresa Starzyńska
Gastroenterology Department, Pomeranian Medical University, 71-242 Szczecin, Poland. bialekab@pam.szczecin.pl

OBJECTIVE To investigate the indications, resection rate, and safety of endoscopic submucosal dissection (ESD) for neoplastic lesions in the gastrointestinal tract at a European referral center. METHODS We carried out a retrospective analysis of the ESD procedures performed in our center for mucosal neoplastic and submucosal lesions of the gastrointestinal tract. The duration of the procedure, en bloc and complete (R0) resection rates, and complication rates were evaluated. Variables were reported as mean ± SD or simple proportions. Univariate analysis and comparisons of procedure times and resection rates were performed using Mann-Whitney U tests, or χ(2) tests for dichotomous variables. RESULTS Between 2007 and 2011, ESD was performed in a total of 103 patients (46.7% male, mean age 64.0 ± 12.7 years). The indications for the procedure were epithelial tumor (n = 54), submucosal tumor (n = 42), or other (n = 7). The total en bloc resection rate was 90.3% (93/103) and R0 resection rate 80.6% (83/103). The median speed of the procedure was 15.0 min/cm(2). The complete resection rate was lower for submucosal tumors arising from the muscle layer (68%, 15/22, P < 0.05). Resection speed was quicker for submucosal tumors localized in the submucosal layer than for lesions arising from the muscularis propria layer (8.1 min/cm(2) vs 17.9 min/cm(2), P < 0.05). The R0 resection rate and speed were better in the last 24 mo (90.1%, 49/54 and 15.3 min/cm(2)) compared to the first 3 years of treatment (73.5%, 36/49, P < 0.05 and 22.0 min/cm(2), P < 0.05). Complications occurred in 14.6% (n = 15) of patients, including perforation in 5.8% (n = 6), pneumoperitoneum in 3.9% (n = 4), delayed bleeding in 1.9% (n = 2), and other in 2.9% (n = 3). Only one patient with delayed perforation required surgical treatment. During the mean follow-up of 26 ± 15.3 mo, among patients with R0 resection, recurrence occurred in one patient (1.2%). CONCLUSIONS ESD is an effective and safe method for resection of neoplastic lesions with low recurrence. Speed and the R0 resection rate increased after 50 procedures.

UI MeSH Term Description Entries
D007889 Leiomyoma A benign tumor derived from smooth muscle tissue, also known as a fibroid tumor. They rarely occur outside of the UTERUS and the GASTROINTESTINAL TRACT but can occur in the SKIN and SUBCUTANEOUS TISSUE, probably arising from the smooth muscle of small blood vessels in these tissues. Fibroid,Fibroid Tumor,Fibroid Uterus,Fibroids, Uterine,Fibroma, Uterine,Fibromyoma,Leiomyoma, Uterine,Fibroid Tumors,Fibroid, Uterine,Fibroids,Fibromas, Uterine,Fibromyomas,Leiomyomas,Tumor, Fibroid,Tumors, Fibroid,Uterine Fibroid,Uterine Fibroids,Uterine Fibroma,Uterine Fibromas,Uterus, Fibroid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004210 Dissection The separation and isolation of tissues for surgical purposes, or for the analysis or study of their structures. Dissections
D005260 Female Females
D005770 Gastrointestinal Neoplasms Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL. Gastrointestinal Cancer,Cancer of Gastrointestinal Tract,Cancer of the Gastrointestinal Tract,Neoplasms, Gastrointestinal,Cancer, Gastrointestinal,Cancers, Gastrointestinal,Gastrointestinal Cancers,Gastrointestinal Neoplasm,Gastrointestinal Tract Cancer,Gastrointestinal Tract Cancers,Neoplasm, Gastrointestinal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Andrzej Białek, and Anna Wiechowska-Kozłowska, and Jan Pertkiewicz, and Katarzyna Karpińska, and Wojciech Marlicz, and Piotr Milkiewicz, and Teresa Starzyńska
June 2020, Expert review of gastroenterology & hepatology,
Andrzej Białek, and Anna Wiechowska-Kozłowska, and Jan Pertkiewicz, and Katarzyna Karpińska, and Wojciech Marlicz, and Piotr Milkiewicz, and Teresa Starzyńska
March 1992, Endoscopy,
Andrzej Białek, and Anna Wiechowska-Kozłowska, and Jan Pertkiewicz, and Katarzyna Karpińska, and Wojciech Marlicz, and Piotr Milkiewicz, and Teresa Starzyńska
January 2013, Endoscopy,
Andrzej Białek, and Anna Wiechowska-Kozłowska, and Jan Pertkiewicz, and Katarzyna Karpińska, and Wojciech Marlicz, and Piotr Milkiewicz, and Teresa Starzyńska
December 2013, Endoscopy,
Andrzej Białek, and Anna Wiechowska-Kozłowska, and Jan Pertkiewicz, and Katarzyna Karpińska, and Wojciech Marlicz, and Piotr Milkiewicz, and Teresa Starzyńska
October 2021, Gastroenterology,
Andrzej Białek, and Anna Wiechowska-Kozłowska, and Jan Pertkiewicz, and Katarzyna Karpińska, and Wojciech Marlicz, and Piotr Milkiewicz, and Teresa Starzyńska
February 2009, Drug design, development and therapy,
Andrzej Białek, and Anna Wiechowska-Kozłowska, and Jan Pertkiewicz, and Katarzyna Karpińska, and Wojciech Marlicz, and Piotr Milkiewicz, and Teresa Starzyńska
January 2015, GE Portuguese journal of gastroenterology,
Andrzej Białek, and Anna Wiechowska-Kozłowska, and Jan Pertkiewicz, and Katarzyna Karpińska, and Wojciech Marlicz, and Piotr Milkiewicz, and Teresa Starzyńska
April 2019, Endoscopy international open,
Andrzej Białek, and Anna Wiechowska-Kozłowska, and Jan Pertkiewicz, and Katarzyna Karpińska, and Wojciech Marlicz, and Piotr Milkiewicz, and Teresa Starzyńska
August 2010, Journal of gastroenterology and hepatology,
Andrzej Białek, and Anna Wiechowska-Kozłowska, and Jan Pertkiewicz, and Katarzyna Karpińska, and Wojciech Marlicz, and Piotr Milkiewicz, and Teresa Starzyńska
March 2020, Surgical endoscopy,
Copied contents to your clipboard!